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PREVALENCE OF RAISED IgE LEVELS AND ABSOLUTE EOSINOPHIL
COUNT IN BRONCHIOLITIS IN CHILDREN AGED 2 MONTHS TO 2 YEARS
IN TERTIARY CARE CENTRE
DR.SINDHU BHARATHI S , POST GRADUATE, MD PAEDIATRICS,STANLEY
MEDICAL COLLEGE
ABSTRACT
TITLE: Prevalence Of Raised IgE Levels And Absolute Eosinophil Count In
Bronchiolitis In Children Aged 2 Months To 2 Years In Tertiary Care Centre.
INTRODUCTION: Bronchiolitis is most common respiratory infection in  children less
than 2 years. The host inflammatory response contribute to the pathophysiology of
bronchiolitis.Most common long term complication is wheeze although the relation
remains unclear
AIMS AND OBJECTIVE: The Primary outcome was To Measure Serum IgE levels
and Absolute Eosinophil count  in patient with bronchiolitis and obtain the prevalence of
raised values and To obtain RSV Antigen assay in these patients as one of the etiology
for Bronchiolitis .The Secondary outcome is To find out the Proportion of occurence of
wheezing among the IgE positive patient.
CONCLUSION:.
The study thus conducted has illuminated us on the following facts
about bronchiolitis.
With regard to the age distribution, higher incidence of bronchiolitis is seen in the
infant population of 2 to 6 months .Higher incidence is seen among the male population
compared to females.
The prevalence of raised Absolute eosinophil count was 28.1 %. They were correlated
with age and  is found to have high statistical significance.
The prevalence of IgE levels in bronchiolitis (38.5%)  but  was not of any statistical
significance.RSV antigen was 35.4 %  as a causative factor and had  high statistical
significance
The proportion of occurence of wheeze among IgE Positive patient was 45.9%
.  Out of raised  IgE levels in 37 patient 17 had wheeze. Among 27 raised absolute
eosinophil levels  10  had wheeze on follow up. Among the bronchiolitis children with
normal values of IgE and Absolute eosinophil count 5 had wheeze on  follow up. Out of
the subjects who have both IgE and absolute eosinophil count raised 3 had wheeze on
follow up.
KEY WORDS: Bronchiolitis, IgE, Absolute eosinophil count.
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INTRODUCTION 
Definition: 
The American Academy of paediatrics 7and Europian respiratory society  
defines bronchiolitis as “A constellation of clinical signs and symptom  
including viral upper respiratory prodrome followed by increased respiratory 
effort and wheeze in children less than 2 years “ 
Bronchiolitis is characterised by acute inflammation,necrosis and edema of 
small airway with increased mucus production. 
Epidemiology : 
Bronchiolitis in children is a most common lower respiratory infection 
diagnosed clinically. It is usually caused by infection of lower airways              
( bronchioles) by virus.  Bronchiolitis occurs in 75% of the children less than   
1 year of age.90% of bronchiolitis occurs in first two years of life. World heath 
organisation has estimated the RSV burden globally as 64 million cases and 
150000 deaths every year.1 
  Many virus cause bronchiolitis with Respiratory syncytial virus being 
common.Sixty to seventy five percent of bronchiolitis is caused by Respiratory 
syncytial virus (RSV). Epidemiology of RSV has many unusual characteristics. 
They infect children nearly in first year of life with the peak incidence in 2 – 8 
months. Its is the only virus which cause most severe respiratory disease in the 
first month of life when there is antibodies from the mother.1  
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 These infection doesnot grant long term immunity with reinfection common 
through out life.  
                   These children  present with respiratory distress, irritability, cough, 
poor feeding and apnoea in very young.These features along with auscultatory 
findings of crepitations and wheeze combine to make the diagnosis of 
bronchiolitis. Bronchiolitis is one of the common cause of hospitalisation. 2 
                    In most of the children the disease is mild and self limiting in 
about  four to seven days. But in some cases it may cause severe illness. The 
most susceptible ones are those with preterm delivery, underlying cardiac or 
respiratory condition2. About 2 to 3 % of children require hospitalisation. 
                    In India the most common cause of morbidity is lower respiratory 
tract infection and bronchiolitis is most common cause. 
Etiology : 
The most common cause  of bronchiolitis is Respiratory syncytial virus. This is 
followed by Enterovirus (17%), Metapneumovirus (7%), Adenovirus. More 
than one virus is seen in about 30% of cases. 
Respiratory syncytial virus:   
RSV virus is Paramyxovirus of genus pneumovirus . It is a medium sized RNA 
virus. The genome is composed of 10 viral proteins and 15000 nucleotides. 
• The nucleocapsid N protein tightly encapsulates the genome which 
along with phosphoprotein P and polymerase subunit L  forms minimum 
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unit for RNA replication.RSV encodes three surface envelope proteins,   
the attachment protein , fusion protein and a small hydrophobic protein. 
There are two protein G , glycoprotein and F fusion protein. G protein 
produces Th2 response and F protein Th1 response. There are two major 
RSV strains (subgroup)A and B.They are distinguished by variations in 
G protein.There is controversy over which subgroup caused more severe 
symptoms . 
Respiratory syncytial virus is one of the most important cause of bronchiolitis.  
In hospitalised patients RSV accounts for 60 to 90 % of lower  respiratory tract 
infection. Severe infection occur in those who are less than 6 months of age. 
Underlying conditions like prematurity, bronchopulmonary dysplasia, 
immunodeficiency, congenital heart disease contribute to severity of disease.  
                 Intensive care is needed for about 15% to 30% of RSV infections. 
Due to respiratory failure , apnoea 7% to 21% of hospitalised patient needs 
mechanical ventilation 7 .Mortality rate is very low ranging from 1% to 3% . 
But the rate increases to 5 to 8% in congenital  heart disease to 13% in chronic  
lung disease. 
          According to CDC , Respiratory syncytial virus infects breathing 
passages and lungs. It can be serious especially in infants and older adults. It is 
most common cause of bronchiolitis in children which is inflammation of 
smaller airways and can also cause pneumonia. When infants are exposed to 
RSV for first time out of 100 , 25 to 40 have signs and symptoms of 
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bronchiolitis . 5 to 20 of 1000 will require hospitalisation. Most will recover in 
1-2 weeks  but in infants with weekened immune system can continue to spread 
infection for 1 to 3 weeks. 
          Whether RSV infection predisposes to wheeze is question for decades. 
Some prospective study have suggested that RSV infection predisposes to 
blood eosinophilia and  airway hyperreactivity leading to development of 
wheeze. Some congenital trait like increased immunological response, small 
airway, increased airway reactivity also contribute to illness. 
 
RSV IMMUNE RESPONSE:
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From the upper respiratory tract the infection spreads to lower respiratory tract. 
The resulting inflammation of bronchioles is characterised by infiltration of 
inflammatory cells and odema of mucosa and adventitia. The viral replication 
result in production of chemokines, cytokines and cause recruitment of 
eosinophils and neutrophils. 
 Macrophages present Viral particles causing bronchiolitis  in association with 
MHC class II to CD4+ T lymphocyte which in turn produce cytokine 
production.TH1 cells are involved in cellular reponse. TH2 cell  cause 
induction  of eosinophilia and immunoglobulin production such as IgE. 
                       Overproduction of cytokines released by Helper 2 T 
lymphocytes   is responsible for illness  especially interleukin 4 and 5. These 
are responsible for wheeze.Interleukin 4 and 5 cause migration of eosinophil 
and also increases IgE production.11  
                           Th2 cell activation  attracts  eosinophils. Virus induced 
eosinophilia can  also occur. 
                         Within 2 days of infection cell bound IgE are detected. The 
titres of IgE  are predictive of recurrant wheezing. This is possibly due to 
similarities in  inflammatory response to allergen exposure and virus infection. 
Long term effects of RSV by pulmonary function test reveal  restrictive 
pulmonary disease and severe airway resistance. 
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Inhibition of Interferons: 
Interferons believed to have antiviral properties,Non structural protein inhibit 
IFN-alpha/beta,Inhibition of IFN-gamma causes enhanced IgE production 
Interleukins & Chemokines: 
Infection induces expression of chemokines  which mimic RSV glycoproteins 
and also recruit monocytes, eosinophils, & neutrophils ,IL-8 levels positively 
associated with severity. 
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Diagnosis : 
Diagnosis of bronchiolitis is mostly clinical  based on presentation , age, 
seasonal and clinical characters. 
 Few investigations are required particularly to exclude other diagnosis               
( pneumonia, congestive cardiac failure) and to know the viral etiology. 
The American Academy of paediatrics7 has given clinical practical  guideline 
for diagnosis of bronchiolitis. This applies to children from 1 to 23 months of 
age. The  key action statements are as follows, 
1a. clinicians shoud diagnose bronchiolitis and assess the disease severity 
based on history and physical examination. ( recommendation strength : strong 
recommendation) 
1b.Clinicians should assess the risk factors for severe disease such as age less 
than 12 weeks, a history of prematurity , underlying cardiopulmonary disease, 
or immunodeficiency , when making decisions about evaluation and 
management of children with bronchiolitis.  
1c. When clinicians diagnose  bronchiolitis on the basis of history and physical 
examination, radiographic or laboratory studies should not be obtained  
routinely. 
The course of bronchiolitis is variable ranging from transient events like 
apnoea to severe respiratory distress. History is important. 
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When assessing bronchiolitis one should consider that its more common in age 
group less than 2 years, peaking between 3 to 6 months. The symptoms usually 
peak at around 3 to 5th day of illness.  In 90% of the patients the cough settles  
within 3 weeks.  
Infants  usually present with Prodromal coryza,Cough ,Tachypnoea or 
respiratory difficulty or both.Crepitation or wheeze on auscultation or both. 
Fever occurs in 30 % of the patients usually less than 39 degree Celsius.In 
infancy less than 6 weeks it may present as apnoea without other clinical sign. 
If the patient has persistant high grade fever,crackles or persistant wheeze 
alternate diagnosis such as pneumonia or early onset asthma should be 
considered. 
If the child has signs of exhaustion or poor respiratory efforts or apnoea suspect 
impending respiratory failure. The children need intensive care. 
Bacteriological and virological testing: 
Rapid virological testing may cause reduction in unnecessary intervention, 
decrease the hospital stay , ,microbiological test and antibiotic use. It is also 
used to prevent nosocomial infection. 
 
 
 
9 
 
Immunoglobulin E: 
 IgE is antibody specific to mammals. When our immune system is exposed to 
environmental allergen or infectious particle which it identifies as potentially 
harmful it produces IgE . These Ig binds with antigen resulting in inflammatory 
response for getting rid of infectious particle. If this Ig is produced in 
overabundance the next encounter with the allergen will produce  more harm 
than with the first exposure. 
         Severity of RSV Infection is Determined By Inhibition of certain 
interferons ,involvement of innate immune system,interleukins and 
chemokines,coinfection with other respiratory viruses. 
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Eosinophils :  
  Since eosinophils have antiviral activity RSV infected epithelial cells 
upregulate the production of eosinophils. They also play importantant role in 
long standing inflammatory reaction in bronchiolitis. 
      Absolute eosinophil count measures no of eosinophils which are white 
blood cells. More than 500 cells per microlitre of blood is considered 
eosinophilia. High count is related to allergic reactions. 
This study intends to know prevalence of serum IgE level  and absolute 
eosinophil count in bronchiolitis and to estimate the occurance of wheeze in 
those with raised   Ig E levels.                        
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REVIEW OF LITERATURE 
 
Etiology of Bronchiolitis: 
                 According to Consensus conference on acute bronchiolitis; In 
population less than 2 years  bronchiolitis forms 1-3.5%  of admissions and 1-
2% of emergency admissions among  age 3-6 months. Prematurity chronic lung 
disease and congenital heart disease are most common risk factor. 2 
Other risk factor is poor socioeconomic status, male,exposure to smoke. Other 
virus involved are Rhinovirus,  Metapneumovirus,Adenovirus,Parainfluenza 
and Bocavirus. 
Immune response in bronchiolitis: 
                            According to Wright, M and Peidimone et al 26 there is  
involvement of Cell-mediated  CD4+ & CD8+ cells and  helper cells 
Th1 and Th2 . RSV specific IgE is cell bound to the mucosal epithelial 
cell  of the respiratory tract ,its amount, persistency and duration are 
important in determining the severity of bronchiolitis and wheezing. IgE 
combines with mast cell to cause inflammatory mediator release  which 
in turn mobilize other cells  and cause release of eosinophil degradation 
products and cytokines. 
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RSV: Co-infection:  
  According to Thornburn K et al63 , Among 165 PICU admissions with 
RSV bronchiolitis ,42%  were mechanically intubated patients in PICU 
with lower airway secretions positive for bacteria  with organisms like 
S.aureus,M.catarrhalis, H.influenza,S.pneumonia and S.Pyogens. 
According to Vincencio 2010 et al severe infection with bronchiolitis is 
multifactorial and is related to host. Environment and virus. Low birth 
weight  children less than 3 months, overcrowding smoking contribute 
to severity. RSV produce more severe disease than other virus. 
 
           Since 1950s , bronchiolitis is used as a diagnosis for a specific clinical 
symptom complex  of respiratory system. After  a short prodrome of upper 
respiratory system typical signs of bronchiolitis like wheezing, tachypnoea, 
respiratory distress ,poor feeding and hyperinflated lung fields occur. Fine 
crepitation is heard on auscultation ( Hall 200199, Simoes 1999, Fitzgerald and 
Kilham 2004, AAP 2006 ).Some studies restrict bronchiolitis to RSV cases 
only(Siguris21 2002, Schauer et al 2002) 
 
            Mullins JA et al 21Greenough et al 23and Parrot RH et al24 studied the 
epidimelogy ,seasonal timing of bronchiolitis.Studies on infants admitted for 
bronchiolitis found 60% to 75% children  have positive test for RSV. One third 
of the infants are found to have co infections.  
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             Among the viruses which cause lower  respiratory tract infection , 
respiratory syncytial virus is most common virus ( Calvo et al.382010, Manoha 
et al 2007, Mansbash et al 2007, Marguet et al 2009,Jartti et al 2004, Midulla et 
al 552010) 
RSV virus has annual outbreaks during rainy season in tropical climates and 
during winter in temperate climates. 
          According to Jartti et al 55   those children with first episode of wheeze 
are considered  for diagnosis of bronchiolitis.   
       Nair H,Nokes DJ et al 73conducted a meta-analysis on global burden of 
RSV bronchiolitis.According to them  RSV incidence is high causing 
substantial impact in family and society . In 2005, RSV bronchiolitis affected 
34 million children globally under five years of age and about 3.4 million 
required hospitalisation.Mortality of RSV Infections was around 66000 with 
99% of which occurs in developing countries. 
      According to Jansen AJ, Sanders et al74 ,Netherlands the annual number of  
hospitalisation due to RSV  and primary care visit are 2400 and 48000 for 
children less than two years and 300 and 35000 for children 2-4 years 
respectively. 
 
      Roosevelt GE Clarke et al 26 and Shay3 DK et al  studied bronchiolitis 
associated hospitalisation and mortality .About 87% of the children are infected 
by 18 months and virtually all children are infected by 3 years of life. Infected 
infants develop upper respiratory tract infection. About 40 % develop lower 
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respiratory tract infection . 1-2% of infants require hospitalisation. In these 
mortality can reach 10 %.  
 
     According to Shay DK Holman et al 3reinfection with RSV occurs 
throughout life  although recurrent bronchiolitis is unlikely.RSV infection 
unusual in less than 1 month and  more than  2 year  of age  and more common 
among 2- 5 months of age.  
 
 Scottish Intercollegiate Guidelines Network 2 gives diagnostic  
 value of clinical characteristics: 
 Effects of  Age: 
There is no evidence for age as determining feature of diagnosing bronchiolitis. 
Its more common between 3 to 6 months of age . Its more commonly 
diagnosed less than 2  years of age .Infections  are more severe in premature 
infants and neonates. 
Fever ,Rhinorrhoea and cough:  
 Dry wheezy cough along with nasal symptoms is more characteristic in 
bronchiolitis. High  fever is uncommon. But infants may have fever or history 
of fever. 
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Dyspnoea : 
Increased rate of respiration is most common symptom in bronchiolitis. 
Subcostal retraction and intercostal retraction are commonly seen in 
bronchiolitis.  They may have typically hyperinflated chest which may 
distinguish from pneumonia. 
Feeding difficulties: 
Poor feeding may be one of the common criteria for admission, but its not 
needed for diagnosis. 
Crackles or crepitation:  
Inspiratory crackles heard all over the lung fields is common in bronchiolitis. 
Viral induced wheeze is considered in  infants with only wheeze. 
Apnoea :  
In premature babies , in low birthweight babies and in very young babies 
apnoea may be presenting feature. 
Investigations : 
Acute bronchiolitis is a clinical diagnosis.  When diagnostic uncertainity exist 
investigations are performed for subsequent management. These investigations 
include pulse oximetry, blood gases, rapid virological and bacteriological 
testing, full blood count, C reactive protein,chest x ray etc. 
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Pulse oximetry:  
 Low oxygen saturation significantly influenze the physician to admit or 
discharge the patient. Low oxygen saturation is associated with severe disease. 
Infants  with saturation <92% require admission and inpatient care. Infants with 
saturation > 94% is fit for discharge. 
Blood gases: 
Usually not indicated. Carbon di oxide level will determine the referral to 
higher intensive care unit. 
Chest x ray: 
Chest x ray is usually not recommended in bronchiolitis. In most of the cases it 
is usually normal. It is usually indicated where there is atypical course or 
uncertainity in diagnosis. The finding in chest x ray may vary from normal to 
hyperinflation, atelectasis or pulmonary infiltrates. 
Bacteriological and virological testing: 
Rapid virological testing may cause reduction in unnecessary intervention, 
decrease the hospital stay , microbiological test and antibiotic use. It is also 
used to prevent nosocomial infection 
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 Comparing age vs bronchiolitis : 
   According to Crowe jr and Williams 2003 et al 101Immune development 
requires interaction of genetic, molecular and cellular components which may 
act differently in different infection and different age. The protective antibody 
responses to viral glycoprotein develop gradually over first  6 months of life, 
reflecting developmental maturation of immune system at birth. The young 
infant mount poor immune responses. This is why they require hospitalisation  
when they acquire respiratory tract infection. Majority of bronchiolitis infection 
occurs in age group less than 3 months. 
         Akdis et al and Miller et al 18 studied immunological reponse in RSV. 
According to him RSV infects respiratory cell and involve macrophages which 
respond by producing cytokines. The cytokines is age dependant . There is 
significant difference in production of  cytokines among < 6 months and > 6 
months.( Hoebee  et al 2004)100. Th 2 cytokines produce IL -4, IL- 5,9 , which 
in turn produce IgE( Ozdemir et al 2009 )102. 
       Immune response clear the infection and limit the spread of virus. 
According to Hallman et al 106 the earliest response to infection is innate 
immune system . These antigens of the microbes are processesed and  form 
complex with major histocompatability complex on the surface of the 
macrophage. They stimulate the T cell receptors, which  in turn produce 
cytokines , recruit eosinophils etc. 
      Viral infection cause bronchial constriction by neural reflux (Bowerfind et 
al 2002 ) 104indirectly or directly by interferon production. Interferon gamma 
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production  and strong pro inflammatory response may be one of the  reason 
for recurrant wheeze after viral infection 
    During one year follow up post bronchiolitis increased IL10 response  was 
associated with subsequent increased risk of wheezing.( Bont et al 2000)105. 
   According to Chatterjee et al 68 2000, Karjalainen et al 2003, Lim et al 1998, 
IL -10 is one of the  important factor produced during viral infection and is 
related to wheezing pathogenesis, IgE levels and eosinophil levels.PCR assay 
should be interpreted with caution because any prolonged viral shedding from 
undetected previous illness may be detected by the assay. 
        
        According to Matti karpoori et al 66susceptibility to bronchiolitis and post 
bronchiolitis wheeze has been discovered to be multifactorial which includes 
host , environment and virus itself. 
 
      Domochowski HP Rosenberg et al 88 studied the immunopathogenesis of 
respiratory syncytial virus infection. There is evidence of eosinophilic 
degranulation in lung parenchyma and nasopharynx during RSV infection. The 
secretion of eosinophilic cationic protein is associated with wheezing.  
     Harrison AM bonvilli et al  studied eosinophil recruitment and 
degranulation and RSV induced chemokine recruitment . According to them 
Eosinophil and eosinophil RNA ase have antiviral activity. Eosinophil 
chemoattactants RANTES and MIP – 1  are upregulated by RSV infected 
respiratory epithelial cells. 
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         Smyth RL, Reinze PM et al 103studied activation of cellular immunity and 
wheezing after bronchiolitis. According to them there is long standing 
inflammatory reaction following RSV infection. 
 
           FeiginRD ,Cherry JD et al 88studied  RSV infectious disease. They 
conducted clinical trials of formalin inactivated vaccine for RSV. Increased 
mortality and morbidity was observed in infants on subsequent exposure.Post 
mortem examination showed massive pulmonary eosinophilic infiltrates. This 
gives strongest evidence for involvement of eosinophils in RSV bronchiolitis 
immunopathogenesis. 
 
      Stein RT sherril et al 79 studied bronchiolitis and wheeze  found IgE in 
respiratory secretions of those recovering from bronchiolitis. In acute 
bronchiolitis level of IgE was high which correlated with degree of hypoxia. 
 
    Korpi matti et al 66did their study to determine clinical characteristic of RSV 
antigen associated with wheezing. In their study 100 children were admitted 
with wheezing  24 children showed RSV infection with raised IgE levels and 
blood eosinophilia. 
 
     David a albert 27et al studied correlated respiratory illness with serum IgE 
levels. According to  them wheezing illness was greater in children with raised 
IgE levels. 
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       Siguris N Bjarnason et al 28did a study  on IgE  antibodies and asthma after 
respiratory  syncytial virus. According to them positive IgE test was found in 
14 out of 44 RSV children. They also concluded that RSV is one of the risk 
factor for sensitisation to allergen and asthma in subsequent 2 years. 
 
     Massimo  vincenzo et al 29in his study concluded that serum IgE levels and 
eosinophils were elevated during bronchiolitis and they developed wheeze on 
follow up. The risk for development of wheeze was  high with eosinophil level 
> 8 microgram compared to those with < 8 microgram (p< 0.0001). 
    Sabina alenka et al 30 concluded that  IgE  antibodies were detected in sera of 
6 RSV positive children with increase in CD23 +B cells.According to them 
CD4lymphocytes were Th2 cells that produces IL4 that plays essential role in 
synthesis of IgE. These cells drive B cells to produce IgE by  physical 
interaction and cytokine production. 
 
    Yechiel becker et al 35 in their study concluded that there is increase in Th2 
cytokines and IgE levels in RSV infected patients suggesting allergy like 
condition is produced during the infection. 
 
       Mark Grenvilli et al  36study has shown that IgE  can be detected in both 
upper and lower respiratory tract of infants with RSV positive bronchiolitis. 
They have  also shown IgE in respiratory tract of two patients intubated for 
RSV bronchiolitis. 
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       Robert williver et al 37 studied the predictive value of raised IgE levels 
following bronchiolitis and subsequent wheeze. According them 70 % of the 
infants with raised IgE level showed subsequent wheezing than in 20 % of 
those who  showed normal IgE levels. 
 
         John F prince 38 et al  studied effects of  bronchiolitis in infancy. 
According to his study  85% of bronchiolitis case showed RSV positivity . 75% 
of the children showed recurrant lower respiratory tract infection . Many  
continued to have hyperinflation of lung and bronchial hyperresponsiveness. 
IgE antibodies and leukotrienes were found in higher concentration in children 
with bronchiolitis. 
  
      Robert C williver et al 40 studied IgE after RSV infection .  He concluded 
that Ig E was found during acute phase of bronchiolitis. Subsequent production 
of chemical mediators of bronchospasm  is responsible for pathogenesis of the 
disease. Recurrant episodes of wheezing is explained by persistence of IgE in 
the respiratory tract. 
   
     According to Weliver et al 41the patients with bronchiolitis who wheezed 
had greater concentration of IgE than those without obstruction. They also had 
greater concentration of histamine. Prospective monitoring also showed that 
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these patients with high titres of IgE developed wheezing on follow up. Family 
history of atopy and positive skin test also contributed to recurrant wheezing. 
 
    Busse Milner Morgan44 et al explained the phenomenon that viral infections 
cause epithelial injury, production of virus specific antibodies, mediator release 
and airway hyperresponsiveness. The infection by virus affect alveolar and 
lung development ,cause airway remodelling and thus predispose to wheeze. 
 
    The association between viral bronchiolitis and wheeze was reported by 
various authors,Schauer et al 2002 reported bronchiolitis at 4 months and 
followed them for 6-9 months when they developed wheeze. Cifuentz et al 
2003 followed for 11 months from 3.5 months of age to report wheeze. They 
also reported that wheezing episodes and asthma shared  genes, there were 
several polymorphism in cytokine gene in asthma which were related to RSV 
severity. 
 
    Shein et al 47conducted a study on blood eosinophilia. According to him  
20 % of children with bronchiolitis had positive eosinophilia. In his study 
positive eosinophilia was associated with increased duration of hospital stay of 
these bronchiolitis patient and increased mechanical ventilation. 
 
       Calvo gracia et al 48studied eosinophilia in bronchiolitis and their 
subsequent development of wheeze. According to them bronchiolitis patient 
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had raise in eosinophils > 1%. Their  first five year follow up showed that 
about 35.3% developed persistant wheeze  
 
        Pifferi  Ragazzo V et al 49studied eosinophils in RSV bronchiolitis. 
According to them among forty eight people who enrolled wheeze was more 
common in those who had raised eosinophils. 
 
     Stephen H Polmer et al 43studied IgE in bronchiolitis. They measured IgE in 
32 subjects. According to them serum IgE was elevated in 35% of the subjects. 
This supported the concept of heterogenous etiology of bronchiolitis. They also 
suggested that these bronchiolitic patients had subsequent risk of developing 
respiratory allergies. 
 
     Murtuza A  Khan Michel et al 51 studied IgE in bronchiolitis. Out of 95 
samples 65 showed raised IgE in acute phase. 
 
    Welliver et al 42studied RSV IgE titre in nasopharyngeal secretions. 
According to them elevated level of IgE  were  predictors of risk of developing 
wheeze in later life. 
 
      Roman M Calhoun et al 87studied the response of Th2 to RSV. According 
to them Th2 response is triggered during viral infection. These Th2 cells 
secrete IL 4,5,6. These interleukin promote eosinophilia and immunoglobulin E 
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synthesis. It is also hypothesised that increase in serum IgE is indirect marker 
of Th2 synthesis in acute broncholitis. 
 
        Garofalo R dorris et al 85 studied eosinophil count in relation to severity of 
bronchiolitis. According to his study eosinophil count were significantly 
greater in patients with  bronchiolitis than those with upper respiratory tract 
infection. The peripheral eosinophil count is suppressed in viral infections 
although the effect is overcome in patient with bronchiolitis. Degranulation of 
eosinophils is related to severity of bronchiolitis. 
 
      Viral infections suppress peripheral blood eosinophil counts in infants 
greater than two months of age, although the effect is somewhat overcome in 
patients with bronchiolitis. The form and severity of bronchiolitis is much more 
strongly related to degranulation of eosinophils in the respiratory tract than to 
peripheral blood eosinophil counts. 
 
      John Henderson Tom N et al 54 did a longitudinal  cohort study on RSV 
bronchiolitis. They admitted 150 patients with RSV bronchiolitis.  The 
prevalence of wheeze was 28.1% in RSV group compared to 9.6% in control 
group. 
 
     Paolo M renzi Jean et al 55studied cellular immunity and Th2 response after 
bronchiolitis. They studies 26 infants without any comorbitidies admitted with 
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bronchiolitis. They found increase in blood eosinophils  and CD4 in patients 
with bronchiolitis. The interleukin 4 levels were also raised. These values were 
more in those infants who wheezed than others. They concluded that 
bronchiolitis is associated with cellular immunity and Th2 response. 
 
     Dimova-Yaneva et  al 56studied eosinophil activation in bronchiolitis. In 
their study they took 78  infants with RSV bronchiolitis. They measured 
cystine leukotrienes and eosinophil by enzyme immunoassay and 
fluroimmunoassay. They identified eosinophils from 51  out of 78 assays. 
      Midulla , Scagnolari  et al 70 studied the prevalence of 14 viruses in infants 
with bronchiolitis.  They studied the demographic and clinical profile of 
bronchiolitis caused by RSV virus, Human bocavirus and Rhinovirus. They 
concluded that major pathogen responsible for bronchiolitis is RSV . Recent 
study conducted   in tertiary care centre in spain revealed that RSV is main 
causative agent for bronchiolitis accounting for 62.7%  of cases. They also 
concluded that RSV positive subjects had longer duration of stay in hospital 
,had frequent PICU admissions ,required oxygen  and caused more illness than 
other viruses. 
      LiuXiaoMei et al 78detected IgE levels in bronchiolitis.During the acute 
stage of bronchiolitis the levels of serum IgE was higher than in control 
subjects. The IgE levels detected was statistically significant.They also 
concluded that the incidence of wheeze was higher in bronchiolitis patient than 
without bronchiolitis. 
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 According to Tucson children respiratory study 84 the most common 
respiratory infection was RSV  and lower respiratory tract caused by RSV is 
most common risk factor for subsequent development of wheeze on follow  up  
upto 6 years. 
         According to Regnier and Huels 82conducted a meta- analysis and 
concluded that the risk of wheeze after bronchiolitis decreased with age.  
        According to Martinez FD Solomon et al 80and Turner SW et al increased 
blood eosinophil count during bronchiolitis is associated with  bronchial 
hyperreactivity. They also concluded that  these Th2 dominated response of 
increased eosinophils and bronchial hyperreactivity could be a risk factor of 
asthma. 
        Kostas N. Priftis, Athina Papadopoulou 90 studied eosinophil and IgE in 
acute bronchiolitis.  They concluded that  IgE levels did not raise significantly 
in study subjects compared to control subjects. The production of IgE is a type 
2  cytokine response produced by stimulation of RSV infection.The mild raise 
in eosinophil level which was statistically significant in their study may be 
attributed to the antiviral nature of eosinophil as they are markers of tissue 
inflammation.They also suggest that raise in eosinophil may also depend on 
history of atopy. This study was supported by Pifferi et al49 .These children face 
recurrant lower respiratory tract infection which is considered as post 
bronchiolitic wheezing and typically cannot be labelled as asthma.90.  
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      According Welliver RC Duffy et al,Sung RY et al,Legg ,Hussain et al 
(91,92)studied IgE levels and cytokine response. The CD23 levels representing 
raised IgE levels are raised in their study. 
     According to Everald et al 93 ,could not find any significant difference in 
study group in IgE levels and bronchiolitis probably because of taking the 
measurement early in the course of disease. 
      Fitch et al  found no difference in eosinophil level and smoking but  
maternal smoking had a dose dependant  relation.94,95 
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                             AIMS AND OBJECTIVE 
Primary outcome:  
1. To Measure Serum IgE levels and Absolute Eosinophil count  in patient 
with bronchiolitis and obtain the prevalence of raised values.  
2.To obtain RSV Antigen assay in these patients as one of the etiology for 
Bronchiolitis  
Secondary outcome:  
To find out the Proportion of occurance of wheezing among the IgE 
positive patient.  
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                  JUSTIFICATION OF STUDY: 
          Bronchiolitis is most common respiratory infection in  children less 
than 2 years. Infection cause significant morbidity in  children and adults 
but more severe in children less than 1 year due to low immunity and 
smaller airways. The host inflammatory response contribute to the 
pathophysiology of bronchiolitis 
              Abnormal T cell response  in bronchiolitis may cause increase in IgE 
production. Eosinophil levels also raise due to cytokine response and antiviral 
action. Studying the raised levels of Absolute eosinophil count and Ig E helps 
us to know the prevalence of these  in  bronchiolitis.The measurement  of these 
helps in identifying these bronchiolitis subjects  as  high risk of developing 
subsequent allergies. 
           From this study the prevalence of Absolute eosinophil count and IgE 
levels  in bronchiolitis are studied. These measurements may be of value in 
identifying those bronchioltic children at high risk for the subsequent 
development of wheeze and other respiratory allergies. 
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                                      METHODOLOGY: 
 
STUDY CENTRE:  
Department of Paediatrics,  
Stanley medical college, Chennai  
 DURATION OF STUDY: August 2014 to April 2015  
 STUDY DESIGN: Cross sectional study 
 
INCLUSION CRITERIA:  
      All  patients aged 2 months to 2 years  admitted in our hospital for 
treatment of first episode of bronchiolitis were included. 
  EXCLUSION CRITERIA:  
 Previous history of wheezing/ use of bronchodilators 
 Preexisting lung disease  
 Bronchopulmonary dysplasia  
 Previous hospital admissions with respiratory tract illnesses 
 Chronic respiratory illness 
 Congenital heart disease / anomalies of chest, lung and heart 
 Pre-existing immunodeficiencies  
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      SAMPLE SIZE :    
 96 based on sample size calculation  
 n=(Zα pq)  
          d  
 Zα  = 1.96  
 P= 50 % prevalence of increased Ig E level and absolute eosinophil 
count  
  q  = 100 – p  
 d = desired precision of prevalence+/- which implies 95% confidence 
limit for prevalence of IgE  
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 MANOEUVRE : 
      Writtern informed consent  is obtained from the parents of the study  
population 
          Ethical committee clearance obtained from institutional ethical 
committee.                          
   Patient are classified as bronchiolitis  clinically .Bronchiolitis is  
a clinical syndrome characterized by acute onset of respiratory symptoms in 
a child  younger than 2 years of age. Typically the initial symptoms of 
upper respiratory tract viral infection such as fever  and coryza progress 
within 4 -6 days to include the evidence of  lower respiratory tract 
involvement with the onset of cough and wheezing  
         Datas  on clinical symptoms as well as family history and 
environmental factors was  obtained for all  96 children participating in 
the study.  Structured proforma was used. Chest x ray and complete 
blood count taken for all patients  
             About 2 ml blood is drawn for  Serum  Ig E and  is measured  by 
electrochemiluminescence immunoassay . 
 Normal value of  IgE : 
 0 to 1 year :0 to 15 IU/ml, 
 1 to 5 year: 0  to 60 IU/ml.  
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                 Absolute eosinophil count is done by direct method  in which blood 
is diluted 10 times in WBC pipette with special diluting fluid which removes 
red cells and stains the eosinophils.  
 Principle : The eosinophil count is performed by diluting whole blood 
with a staining solution. The phyloxine B present in the diluting fluid stains 
only the eosinophils red; all other leukocytes are preserved but not stained. The 
diluted specimen is charged onto a hemacytometer for counting. Using the low-
power (10x) objective, the eosinophils appear bright orange-red and are clearly 
distinguishable from neutrophils, basophils, lymphocytes, and monocytes, 
which do not stain. 
                     The diluted blood specimen is then charged in a counting 
chamber and the cells are counted under high power objective. The 
population of eosinophils is then calculated for the undiluted blood . 
Less than 350 cells per microliter (cells/mcL) is considered normal. 
                         Throat swab for RSV antigen  is taken from posterior 
pharyngeal wall and transported to lab through viral transport medium  using 
cold chain   and  is measured using Polymerase chain reaction  
                      These patients are followed for a period  of 1 year  to find out 
the proportion of occurence of wheezing among the IgE positive patient.  
The patients were followed every two months with telephone call for 
occurrence of wheeze. Those with wheeze were also followed up for further 
recurrence.Results are analysed statistically.  
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                                     OBSERVATION AND RESULTS 
    Analysis of the data  collected has been done and statistical significance was 
established as discussed in following section 
 
     AGE DISTRIBUTION: 
Of the 96 bronchiolitis patients, distribution based on age were analysed and 
the corresponding chart is shown as below. 
 
Figure 1. AGE DISTRIBUTION OF BRONCHIOLITIS 
FIGURE 1 represent that  out of 96 subjects 53 ( 55.2%) were in age group of 2 
to 6 months which was majority followed by 7 months to 1 year with 38 
patients and above 1 year with 5 patients 
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SEX DISTRIBUTION 
         Out of 96 patient who developed bronchiolitis  62%  (60) were male  and 
38 %( 36) were female, with male to female ratio of 5:3 
 
 
Figure 2: Sex distribution of bronchiolitis 
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PRESENTING COMPLAINTS: 
Among the 96 bronchiolitis patient  other than breathlessness which is 
invariably the presenting complaint the other complaints for which  they 
presented are Rhinorrhoea(11.4%),fever (31.2%),cough(16.6%),aspiration 
(16.6%),poor feeding (7.2%),excessive sleepiness(8.3%),ear discharge(1%). 
 
 
Figure 3: Presenting complaint of bronchiolitic patients 
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FINDINGS ON CHEST X RAY:  
 
 
Figure 4: Findings on x ray chest 
Though chest x ray is not an investigation recommended routinely in 
bronchiolitis, we took x ray to rule out other co morbidities. The findings are as 
follows. Among 96 subjects 45 patients showed normal x ray. 35 (36.4%) had 
hyperinflated lungs, 11(11.4%) had consolidation, 5(5.2%) showed increased 
bronchovascular markings. 
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ESTIMATION OF IgE LEVELS 
 
 
Figure 5: IgE levels in bronchiolitis subjects 
As seen from above chart  37 out of 96 subjects  had raised IgE which accounts 
for 38.5%, while the remaining had normal levels. 
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Figure 6: SERUM IgE with age 
As  seen in the above chart  among 53 patients 20 had raised IgE levels in the 
age group of 2 to 6 months. In the age group of 7-12 months 16 had raised IgE 
levels and above 12 months 1 had raised IgE levels. 
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ABSOLUTE EOSINOPHIL COUNT: 
 
 
Figure 7: Absolute eosinophil count in bronchiolitis 
As seen from the above chart out of 96 subjects 28.1% (27) had  raised absolute 
eosinophil count levels .Rest 69 subjects had  normal levels. 
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Figure 8 : Comparision of absolute eosinophil count with age 
The above chart  represents elevation of eosinophil count with age. As seen 
from above among 33 patients in less than 6 months 20 had raised levels and 
among age group of 7 to 12 months 6 had raised levels. 
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Figure 9: Percentage of IgE and Absolute eosinophil count  
   The above figure represent  percentage of  elevated IgE levels (38.5%)and 
eosinophil count (28.1%).  
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RSV AS AN ETIOLOGICAL AGENT IN BRONCHIOLITIS: 
 
 
Figure 8: RSV positivity among bronchiolitic patients. 
The above chart represent RSV positivity among bronchiolitis patient. Among 
96 patient 34 (35.4%) had  RSV PCR positive. 
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Figure 9: Relationship of RSV PCR with Age 
As seen from above chart RSV is more common in age group upto 6 months 
forming 32% followed by 7-12 months with 3% 
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VIRAL BRONCHIOLITIS AND SUBSEQUENT WHEEZE: 
 
 
Figure 10: Proportion of occurence of wheeze among elevated IgE on revisit 
From the above chart out of 37 subjects who had raised IgE Levels .Out of 
them 17 (45.9%) developed wheeze after bronchiolitis on  one year  follow up. 
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FIGURE 11: Subsequent wheezing following bronchiolitis with  Raised IgE 
As seen from the graph, this represent subsequent wheeze following 
bronchiolitis. (With raised IgE)out of 17 patients who developed wheeze 3 of 
them developed wheeze on 9 months of follow up ( age of bronchiolitis 3 
months), 6 on 11 months of follow up ( age of bronchiolitis 5 months) and 8 on 
12 months of follow up ( age of bronchiolitis 4 months). 
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FIGURE 12: Occurrence of wheeze in bronchiolitis 
This figure represents occurrence of wheeze among  bronchiolitis children. Out 
of raised  IgE levels in 37 patient 17 had wheeze. Among 27 raised absolute 
eosinophil levels 10  had wheeze on follow up. Among the bronchiolitis 
children with normal values of IgE and Absolute eosinophil count 5 had 
wheeze on  follow up. Out of the subjects who have both IgE and absolute 
eosinophil count raised 3 had wheeze on follow up. 
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STATISTICAL ANALYSIS 
                                  The collected data was analysed with SPSS 16.0 
version.To describe about the data descriptive statistics frequency analysis, 
percentage analysis were used for categorical variables and the mean & S.D 
were used for continuous variables.To find the significance in categorical data 
Chi-Square test was used. In the above statistical tools the probability value 
0.05 is considered as significant level.  
 
P - 
Value Highly Significant at P ≤ .01 
 
 
    P -
Value No Significant at P ≥ .05 
 
 
 
 
 
 
49 
 
CROSS TABULATION BETWEEN VARIOUS PARAMETERS AND 
DESCRIPTIVE STATISTICS 
  Frequency Table 
FREQUENCY TABLE FOR AGE 
Table 1 
  
Freque
ncy Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Upto 6 
month
s 
53 55.2 55.2 55.2 
7 - 12 
Month
s 
38 39.6 39.6 94.8 
Above 
12 
month
s 
5 5.2 5.2 100.0 
Total 96 100.0 100.0   
From the above chart it is evident that bronchiolitis is more common in 
less than  6 months of age with cumulative percent of 55.2 
 
50 
 
FREQUENCY TABLE FOR GENDER 
Table 2 
  Frequency Percent 
Valid 
Percent Cumulative Percent 
Valid Female 36 37.5 37.5 37.5 
Male 60 62.5 62.5 100.0 
Total 96 100.0 100.0   
 
As seen from the above table out of 96 members 36 were female and 60 
were  male. Their valid percent is female (37.5%) and male (62.5%) 
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PRESENTING COMPLAINTS 
 
 The following chart represents frequency table of presenting complaint.  
KEY FOR CODES 
 Fever ( 1) 
Rhinorrhoea ( 2) 
Cough (3) 
Breathlessness (4) 
Poor feeding ( 5 ) 
Aspiration (6) 
Ear discharge (7) 
Excessive sleepiness (8) 
Congenital heart disease( 9) 
 
 
                   
 
 
                              
52 
 
 Table 3 
 Presenting 
complaint Frequency Percent Valid Percent 
Cumulative 
Percent 
 1,2,4 4 4.2 4.2 4.2 
1,3,4 1 1.0 1.0 5.2 
1,4 10 10.4 10.4 15.6 
1,4,2 1 1.0 1.0 16.7 
1,4,3 2 2.1 2.1 18.8 
1,4,3,2 1 1.0 1.0 19.8 
1,4,5,6 2 2.1 2.1 21.9 
1,4,6 1 1.0 1.0 22.9 
2,4 1 1.0 1.0 24.0 
3,4 4 4.2 4.2 28.1 
3,4,6,1,2 1 1.0 1.0 29.2 
3,4,7 1 1.0 1.0 30.2 
4,1 2 2.1 2.1 32.3 
4,1,3 1 1.0 1.0 33.3 
4,1,3,2 1 1.0 1.0 34.4 
4,1,8,6 1 1.0 1.0 35.4 
4,3 2 2.1 2.1 37.5 
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Table3 
(cont) 
 
     
Presenting 
complaint Frequency Percent Valid Percent 
Cumulative 
Percent 
 
     4,5,6 2 2.1 2.1 41.7 
4,5,6,1 1 1.0 1.0 42.7 
4,5,6,8,1 1 1.0 1.0 43.8 
4,6 4 4.2 4.2 47.9 
4,6,5,8 1 1.0 1.0 49.0 
4,6,8 2 2.1 2.1 51.0 
4,8 3 3.1 3.1 54.2 
4. 44 45.8 45.8 100.0 
Total 96 100.0 100.0   
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FREQUENCY TABLE FOR SERUM IgE 
Table 4 
 
SERUM IGE 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Elevated 37 38.5 38.5 38.5 
Normal 59 61.5 61.5 100.0 
Total 96 100.0 100.0   
      
 
 
As seen from the above chart the valid percent of elevated IgE is 38.5 with 
normal values being 61.5 
 
 
 
 
 
 
 
 
55 
 
 
 
FREQUENCY TABLE FOR ABSOLUTE EOSINOPHIL COUNT 
Table 5 
AEC 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Elevated 27 28.1 28.1 28.1 
Normal 69 71.9 71.9 100.0 
Total 96 100.0 100.0   
 
As seen from the above chart the valid percent of elevated absolute 
eosinophil count is 28.1 with normal absolute count being 71.9 
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FREQUENCY TABLE FOR RSV ANTIGEN 
 
Table 6 
RSV PCR 
 
  Frequency Percent 
Valid 
Percent Cumulative Percent 
Valid Negative 62 64.5 64.5 64.5 
Positive 34 35.4 35.4 100.0 
Total 96 100.0 100.0   
 
As seen from the above chart the valid percent of RSV antigen being positive 
is 35.4 with negative value being 64.5 
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FREQUENCY TABLE FOR CHEST X RAY 
Table 7 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Bilateral 
Hyperinflation 
35 36.5 36.5 36.5 
Increased 
bronchovascular 
markings 
5 5.2 5.2 41.7 
Consolidation 11 11.5 11.5 53.1 
Normal 45 46.9 46.9 100.0 
Total 96 100.0 100.0   
 
As  seen from the above chart bronchiolitis patient had normal x ray  with 
valid percent of 46.9 followed by hyperinflated x ray 36.5% 
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Descriptive 
statistics 
    Table 8 
     Descriptive Statistics for age 
  N Minimum Maximum Mean 
Std. 
Deviation 
AGE IN 
MONTHS 
96 2 19 6.92 3.346 
Hb 96 10 15 12.33 1.092 
Valid N 
(listwise) 
96         
  
 
The above chart gives descriptive statistics for age with minimum 
occurance of bronchiolitis at 2 months of age and maximum occurance 
at 19 months of age, with mean age of 6.92 
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Table 9 
Descriptive Statistics for female 
  N Minimum Maximum Mean Std. Deviation 
AGE IN 
MONTHS 
36 3 15 7.06 2.985 
Hb 36 10 14 11.97 1.055 
Valid N 
(listwise) 
36         
    
The above chart represents descriptive statistics for females with minimal 
occurance of  bronchiolitis at 3 months and maximum at 15 months 
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Table 10 
Descriptive Statistics for male 
       
  N Minimum Maximum Mean Std. Deviation 
AGE IN 
MONTH
S 
60 2 19 6.83 3.566 
Hb 60 10 15 12.55 1.064 
Valid N 
(listwise) 
60         
    
The above chart represents descriptive statistics for  males with minimal 
occurance of  bronchiolitis at 2 months and maximum at 19 months 
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CROSS TABULATION BETWEEN VARIOUS PARAMETERS  
  
 
Table 11 
 
 
 
SERUM IGE * Age 
     
       CORELATION BETWEEN AGE DISTRIBUTION AND SERUM IgE 
  
Age 
Total 
Upto 6 
month 
7 - 12 
month 
Above 
12 
months 
SERUM IgE Elevate Count 20 16 1 37 
% within Age 37.7% 42.1% 20.0% 38.5
% 
Normal Count 33 22 4 59 
% within Age 62.3% 57.9% 80.0% 61.5
% 
Total Count 53 38 5 96 
% within Age 100.0% 100.0% 100.0
% 
100.0
% 
 
As seen from the above table out of 37 elevated IgE levels, 20 belong to 2-6 
months and 16 of them fall under 7-12 months and one of them is above 1 year 
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Table 12 :Chi-Square Tests 
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-
Square 
.944a 2 .624 
Likelihood 
Ratio 
1.013 2 .602 
N of Valid 
Cases 
96     
  
To determine the significane of above categorical data, Pearson chi square test 
was performed. The calculated P value was 0.624 (>0.05). Hence serum IgE 
Levels with regards to age in study population has not been found to be 
statistically significant.  
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AEC * Age. Table 13 
CROSS TABULATION BETWEEN ABSOLUTE 
EOSINOPHIL COUNT. 
 
  
Age 
Total 
Upto 6 
months 
7 - 12 
months 
Above 
12 
months 
AEC elevated Count 11 11 5 27 
% 
within 
Age 
20.8% 28.9% 100.0% 28.1% 
normal Count 42 27 0 69 
% 
within 
Age 
79.2% 71.1% 0.0% 71.9% 
Total Count 53 38 5 96 
% 
within 
Age 
100.0% 100.0% 100.0% 100.0% 
As seen from the above table among the 27 elevated absolute eosinophil count 
11 were in age group 2-6 months  and 11 were in 7-12 months and 5 above 12 
months 
64 
 
Table 14 
  Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 14.215 2 .001 
Likelihood Ratio 14.212 2 .001 
N of Valid Cases 96     
 
 
To determine the significance of above categorical data pearson chi square test was 
performed. The calculated P value was 0.001(0.01).H ence the correlation between 
age and absolute eosinophil count has been found to bear a high statistical 
significance. 
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RSV PCR * Age 
Crosstabulation between RSV PCR and age 
Table 15 
  
Age 
Total 
Upto 6 
months 
7 – 12 
months 
Above 12 
months 
RSV 
PCR 
negative Count 22 35 5 62 
% within 
Age 
41.5% 92.1% 100.0% 64.5% 
positive Count 31 3 0 34 
% within 
Age 
58.5% 7.8% 0.0% 35.4% 
Total Count 53 38 5 96 
% within 
Age 
100.0
% 
100.0% 100.0% 100.0% 
As seen from the above table RSV PCR was positive with 58.5% 
up within the age group of 2-6 months followed by 7.8% among 
7 -12 months 
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  Table 16: Chi-Square Tests 
  Value df 
Asym
p. Sig. 
(2-
sided) 
Pearson 
Chi-
Square 
13.296
a 
2 .001 
Likelihoo
d Ratio 
15.296 2 .000 
N of 
Valid 
Cases 
96     
    
To determine the significance for the above categorical data pearson chi square test 
was performed. The P value  arrived was 0.001 (< 0.01). Hence the correlation 
between RSV antigen and age has been found to bear high statistical significance. 
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  DISCUSSION 
             In  our study ,the prevalence of raised Absolute eosinophil count was 28.1 % 
and IgE levels in bronchiolitis (38.5%)  RSV antigen was 35.4 %  as a causative 
factor and the proportion of occurance of wheeze among IgE Positive patient was 
45.9%. The pathology  of eosinophil activation and type 2 cytokine activated IgE 
production occurs whether the bronchiolitis is  RSV positive or not. 
PRESENTING COMPLAINTS IN BRONCHIOLITIS: 
Among the 96 bronchiolitis patient  other than breathlessness which is invariably the 
presenting complaint the other complaints for which  they presented are 
rhinorrhoea(11.4%),fever (31.2%),cough(16.6%),aspiration (16.6%),poor feeding 
(7.2%),excessive sleepiness(8.3%),ear discharge(1%). Similar study was conducted 
by Losartales ,Maria et al 72where they found 8.6% of RSV infection in outpatient 
department and 10.6% of those in inpatient department wit lower respiratory tract 
infection. In their study 59.7% had lower respiratory tract involvement.chest 
indrawing and increased respiratory rate was invariably present. Wheezing was 
infrequent. 4.6% had bacterial coinfection with low case fatality rate of 3.4%. 
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AGE DISTRIBUTION OF BRONCHIOLITIS: 
The five year survey of admission due to bronchiolitis and RSV infection observed 
increased susceptibility of infants less than one year.16 This is consistent with 
previous studies by  Chatterjee et al,Siguris et al, willi et al, Jartti et al (67,68)in which 
bronchiolitis was associated with lower age group( 2-6 months). In our study among 
96 subjects 55% fell under 2 to 6 months, and 39% had bronchiolitis from seven to 
one year of life. 
GENDER: 
In our study out of 96 subjects bronchiolitis was more common in male (60%) 
compared to females. Similar result was given by Boezen HM, Jansen DF et al 96 boys 
had more risk of developing bronchiolitis than girls which may be due to smaller 
airway in males with decreased flow rate of air in lungs of boys. The 
immunosuppressive  quality of androgen may be a contributing factor. 
INCIDENCE OF  RSV BRONCHIOLITIS: 
Our study reported RSV infection of  35.4% and had high statistical significance. 
Similar studies were conducted by  Soham gupta, Rajini et al57 who reported RSV 
infection among 22 % of children. Yeolekar et al59 reported 26% in west india. Bharaj 
et al 58reported 22%  and Broor et al60 reported 30 % bronchiolitis with causative 
agent as RSV.  
Chattopadhya et al 68reported 54% of RSV infection aming bronchiolitis. According  
to Matti korppi ,villi et al 66 among his bronchiolitis subjects , 69.8 % of  them  had 
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RSV as viral etiology: 
This table represents the prevalence of RSV in various studies (comparing our study ) 
Country  Study size Prevalence 
of RSV  
Age 
Group 
affected  
 Authors 
Our study  96 35.4% < 2 years  
AAP  50-60%   
India 131 54% <2 years Chattopadya, anand R et 
al 68 
Turkey  332 29.5% < 2 years Kanra et al 2005 
UAE 252 28.6% < 2 years Uduman SA et al64 1993 - 
1995 
Lebaon  120 26.7% < 6 years Hamze A et al 2007-2008 
Kuwait  1024 36.8% <1 year Khadada M. et al 612010 
 
 
 
 
 
 
 
 
 
 
AAP- American academy of paediatrics. 
To establish the diagnosis of RSV laboratory diagnosis is essential as clinical features 
overlap with other viral infection like Metapneumovirus. Early diagnosis establish 
timely intervention to be introduced to control the spread of disease.  
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We used amplification technique reverse transcriptase polymerase chain reaction 
 ( RT-PCR) This was supported by  Javed Akthar et al65. 
 
CHEST X RAY IN  BRONCHIOLITIS: 
      According to  Javed Akthar et al 65in bronchiolitis the usual chest x ray picture is 
hyperinflated lung fields with diffuse increase in interstitial markings. They also 
stated that 20- 25% of cases had atelectasis and pulmonary infiltrates.   In our study 
36% of those had hyperinflated lung fields and 44% showed normal x ray. 1% of 
them showed atelectasis and 11% of them had pulmonary infiltrates. 
IgE LEVELS IN BRONCHIOLITIS AND OCCURENCE OF WHEEZE: 
     According to Stephen H. polmer et al33 measured IgE levels in 32 subjects. In his 
study 35% of them had IgE levels above     95 th percentile and among 32 subjects 17 
were RSV positive .In our study 38.5% had raised IgE levels and among 96 subjects 
34 (35.4%) were RSV Positive. But it was statistically not significant.  
     Kostas N. Priftis, Athina Papadopoulou 89 conducted similar study. The aim of the 
study is to test whether serum IgE levels and eosinophil count are raised during acute 
bronchiolitis. They concluded that  IgE levels did not raise significantly in study 
subjects compared to control subjects 
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  Similar  study by Wellivir et al 41,had 78 infants with RSV bronchiolitis .More than 
25 subjects showed raised IgE level and among them 17 had wheeze on follow up. In 
our study among the raised IgE levels ( 37 subjects) 45% (17 subjects) of them 
acquired wheeze. Similar study was conducted by Siguris et al 28 positive IgE test was 
seen in 32% of RSV bronchiolitis and 23% of them developed wheeze. 
 
           Similar study was conducted by Susan P, Paelo et al55 where they concluded 
that bronchiolitis is followed by activation of cellular response  and  early 
wheeze.They also documented increase in eosinophils. Willever sun et al 41in their 
study predicted the  high IgE levels at the time of bronchiolitis is predictive of 
wheeze. In their study about  70% had wheeze episodes after high level. 
EOSINOPHILS IN BRONCHIOLITIS: 
Kostas N. Priftis, Athina Papadopoulou 89   in their study concluded that eosinophil 
level raised slightly and significantly in bronchiolitis. This was similar to our study in 
which though the raise in eosinophil was low it was statistically significant.Another 
study by Oyamer et al 96   found raised eosinophil levels in RSV bronchiolitis than in 
non RSV group and also concluded that RSV caused more severe disease than other 
viruses. Dimova, Russel et al 56reported 51 samples of raised eosinophil count among 
77 bronchiolitis subjects. In our study 28.1% had raised eosinophil count and had 
high statistical significance.Similiar reports were given by Ehlenfield et al and 
Welliver et al, Dorris et al 85, Colochyo et al. 
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   Prevention   of bronchiolitis depends upon diagnosis,control of infection and 
hygiene and also by giving immunoprophylaxis7 (Palivizumab, a genetically 
engineered humanized monoclonal antibody).This monoclonal antibody is  
considered for infants with chronic lung disease, born preterm or with congenital 
heart disease. Infants should not be exposed to passive smoking. Breast milk is 
recommended as it is immunoprotective and decrease the child’s risk of having lower 
respiratory tract infection. 
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                                        CONCLUSION 
 
                      Bronchiolitis is most common respiratory infection in  children less 
than 2 years. The host inflammatory response contribute to the pathophysiology of 
bronchiolitis.Most common long term complication is wheeze although the relation 
remains unclear.                              
              The study thus conducted has illuminated us on the following facts about 
bronchiolitis.  
With regard to the age distribution, higher incidence of bronchiolitis is seen in 
the infant population of 2 to 6 months . 
Higher incidence is seen among the male population compared to females. 
The prevalence of raised Absolute eosinophil count was 28.1 %. They were 
correlated with age and  is found to have high statistical significance. 
 The prevalence of IgE levels in bronchiolitis (38.5%)  but  was not of any statistical 
significance. 
RSV antigen   as a causative factor  was 35.4 %  and had  high statistical significance. 
The Occurence of wheeze was also analysed and was found to be statistically 
significant. 
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                  The proportion of occurence of wheeze among IgE Positive patient was 
45.9%   .  Out of raised  IgE levels in 37 patient 17 had wheeze. Among 27 raised 
absolute eosinophil levels  10  had wheeze on follow up. Among the bronchiolitis 
children with normal values of IgE and Absolute eosinophil count 5 had wheeze on  
follow up. Out of the subjects who have both IgE and absolute eosinophil count 
raised 3 had wheeze on follow up. 
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   LIMITATION OF STUDY 
• The lack of control group without bronchiolitis  for comparision is not done. 
• The comparision between different viral group as a cause of bronchiolitis is 
not done 
• The analysis of coinfection is not done 
• Time period for follow up for wheeze is limited. 
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SERUM IGE LEVELS AND ABSOLUTE EOSINOPHIL COUNT IN         
CHILDREN WITH BRONCHIOLITIS 
PROFORMA 
NAME: 
AGE: 
SEX: 
            HISTORY: 
PRESENTING ILLNESS: 
 PRESENT ABSENT 
FEVER   
RHINORRHOEA   
COUGH   
BREATHLESSNESS   
POOR FEEDING   
ASPIRATION   
EAR DISCHARGE   
EXCESSIVESLEEPINESS   
CONGENITAL HEART DISEASE   
               
ALLERGIC HISTORY : PRESENT ABSENT 
PRECIPITATING FACTORS   
URI    
CHOCOLATE   
CHILLED FOOD   
FRUITS /NUTS   
ENVIRONMENTAL POLLUTION    
 PARENTRAL SMOKING    
SOCIOECONOMIC STATUS:   
OVERCROWDING   
DAMP AND COLD HOUSING   
PAST HISTORY :   
ANY SIMILIAR ILLNESS IN THE PAST   
IF YES HOW MANY EPISODES SO FAR   
BIRTH HISTORY :   
PREMATURITY   
BREAST FEEDING   
        FAMILY HISTORY OF ATOPY /EZCEMA/ASTHMA:  
 
94 
 
EXAMINATION: PRESENT ABSENT 
NUTRITIONAL STATUS   
FEBRILE   
PALLOR/ICTERUS/CYANOSIS   
LYMPH NODE ENLARGEMENT   
VITALS    
RR   
HR   
SPO2   
PERIPHERIES   
RS EXAMINATION:   
CHEST WALL DEFORMITY   
INCREASED WORK OF BREATHING   
WHEEZE   
CRACKLES/CREPTS   
APNOEA   
CVS 
P/A 
CNS 
 
 
LAB INVESTIGATIONS VALUES INFERENCE 
SERUM IGE   
ABSOLUTE EOSINOPHIL COUNT   
RSV ANTIGEN   
CHEST X RAY   
 
FOLLOW UP: 
CONTACT DETAILS 
H/O BREATHLESSNESS   
EPISODIC   
H/O RECURRANT NEBULISATION   
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ORIGINALITY SCREEN SHOT 
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Follow up Chart 
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S.NO NAME AGE IN MONTHS SEX PRESENTING COMPLAINTS Hb TC DC SERUM IGE(n=37) AEC(n=27) RSV PCR(n=34) CXR occurrence of wheeze on follow up(n=29)
1 SHREE 6 F 4,6 10.8 7500 P70L30 elevated normal positive 1 0
2 PREETI 15 F 1,2,4 9.8 11000 P30L62E8 normal elevated negative 4 0
3 NITIN 12 M 1,2,4 11.2 6200 P58L38E4 normal elevated negative 4 0
4 KARPAGAM 6 F 4,5,6 13 11000 P64L32E4 normal elevated positive 4 0
5 YUVA 9 M 4 12.3 10000 P60L40 elevated normal negative 5 0
6 HAARISH 8 M 4 10.7 4600 P70L30 elevated normal negative 5 0
7 AKAASH 9 M 4 13 8600 P64L36 elevated elevated negative 5 0
8 DHARSHINI 11 F 4,1,3 9.8 7000 P62L38 elevated normal negative 1 0
9 PRADEEP 7 M 4 12.4 9000 P68L32 normal normal negative 5 1
10 PONMALAR 8 F 4 13.4 7500 P54L46 normal normal negative 5 0
11 ALBERT 5 M 4,3 12.4 12000 P54L42E4 normal elevated negative 1 1
12 SHANKARI 12 F 1,4,2 9.6 9400 P54L44E2 elevated elevated negative 5 0
13 RAJASEKAR 11 M 1,4 12.9 4600 P60L40 normal normal negative 5 0
14 ABINAYA 2 M 4 13.4 5780 P58L38E2 normal normal positive 1,3 1
15 VISHWA 19 M 1,4,3,2 10.1 11000 P56L44E2 elevated elevated negative 5 0
16 ROHIT 12 M 1,4 12.6 4900 P56L40E4 normal elevated negative 5 0
17 MAGESH 16 M 4,3,2 13 6700 P58L38E4 normal elevated negative 5 0
18 PREETHA 12 F 4,1,3,2 11.5 12700 P60L38E2 elevated normal negative 4 1
19 NAVEEN 14 M 4,3,2 13 10000 P66L34 normal elevated negative 5 0
20 IRFAN 8 M 4 14 6500 P74L26 normal normal negative 5 0
21 HARI 8 M 4 13 4900 P68L32 normal normal negative 5 0
22 HARISHA 5 F 4,3 12.4 7800 P38L60E2 elevated normal positive 1 0
23 MOHAMMED A 10 M 1,4,3 13.5 12000 P54L42E4 elevated elevated negative 4 0
24 KANDAN 6 M 4,6,8 12.6 10000 P54L46 normal normal negative 5 1
25 PRASAD 9 M 4 12.6 8700 P60L40 normal normal positive 1 0
26 NOUSHED 6 M 4 13.6 4800 P70L30 elevated normal negative 1 0
27 KAMESH 4 M 4 12.6 4300 P58L40E2 normal normal positive 5 1
28 MAHA 7 F 1,4 12.4 9000 P54L44E4 normal elevated negative 5 1
29 DHANUSH 3 M 4 13.2 7600 P58L38E2 elevated normal positive 1 1
30 BRINDHA 6 F 4 12.4 5600 P56L40E2 normal normal negative 3 0
31 SARAN 6 M 4,1 12.5 5400 P48L52 normal normal positive 5 0
32 SAM 4 M 4 13.5 7900 P70L30 elevated normal negative 1 1
33 ROOKAYA 3 F 4,6 12.6 6900 P74L26 normal normal positive 1 0
34 LOGESH 5 M 4 12.8 5800 P68L32 normal normal positive 5 1
35 PARI 4 M 4 13.8 5400 P64L36 normal normal positive 1 0
36 ESHWARAN 5 M 4 12.4 9500 P62L38 normal normal positive 1 0
37 GOWRI 10 F 1,4,3 13.4 9900 P54L44E2 normal elevated negative 5 0
38 VANI 5 F 1,4 12.5 7600 P74L26 normal elevated positive 5 1
39 DEPA 4 F 4 11.4 5600 P58L40E2 elevated normal negative 5 1
40 PREM 6 M 4 12.5 6700 P56L40E4 normal elevated positive 5 1
41 VANDANA 4 F 4 13.4 8700 P54L44E2 normal normal positive 1 0
42 ANAND 6 M 1,4 11 9000 P66L34 normal normal negative 5 0
43 JOHN 3 M 4 13 5700 P74L26 normal elevated positive 3 1
44 LAVANYA 7 F 4 12.5 5900 P68L32 elevated normal negative 5 0
45 JESSY 3 F 1,4 13.4 4800 P38L60E2 normal normal positive 1 0
46 SUBU 6 F 4 12.4 6700 P54L42E4 normal normal negative 3 0
47 DEVAND 4 M 4 13.4 7800 P54L46 normal normal positive 1 0
48 CELINA 10 F 4 11.8 5600 P60L40 Elevated normal negative 5 0
49 JUSTIN 6 M 4 13.2 4900 P70L30 normal normal negative 5 0
50 ANITHA 9 F 1,4 12.5 10100 P58L40E2 normal normal negative 5 0
51 SRINIVASAN 4 M 4 13.9 7000 P54L44E4 elevated normal positive 1 1
52 KANIMOZHI 7 F 4 13.6 5300 P58L38E2 elevated normal negative 5 0
53 MEIANA 9 F 4,1 11.4 12100 P56L40E2 normal normal negative 1 0
54 ROSHAN 7 M 4 12.6 7800 P48L52 elevated normal negative 5 0
55 MALARVIZHI 12 F 1,2,4 12.7 11000 P70L30 normal elevated negative 5 0
56 THIRU 5 M 4 12.5 8900 P74L26 normal normal negative 5 0
57 PAVI 11 M 1,2,4 11.4 4600 P68L32 normal normal negative 5 0
58 MARAN 7 M 4 13.5 5670 P64L36 normal normal negative 5 0
59 MOHAN 7 M 4 12.8 5400 P54L44E4 elevated normal positive 5 0
60 ASHWIN 3 M 4,1,8,6 13.6 11900 P58L38E2 elevated normal positive 2,4 1
61 JANAT 5 M 1,4,5,6 12.8 12800 P56L40E2 elevated normal negative 4 1
62 FIRDOSE 15 M 3,4,6,1,2 11.3 10200 P48L52 normal elevated negative 4 0
63 TAFIQ 11 M 3,4 12.4 9000 P70L30 normal normal negative 5 0
64 MANISH 9 M 4 13.4 6800 P74L26 normal normal negative 5 0
65 UMAR 6 M 4 12.5 4500 P68L32 elevated normal negative 5 0
66 PUNITA 8 F 3,4 12.5 5600 P64L36 elevated normal negative 5 0
67 KEVIN 5 M 4 14.6 6500 P62L38 normal elevated positive 1 1
68 PRIYAN 7 M 2,4 11.4 7500 P54L44E2 elevated normal negative 5 0
69 ARASU 9 M 4 13.4 8600 P74L26 normal normal negative 5 0
70 AKILAN 5 M 1,4 12.4 5400 P58L40E2 elevated elevated negative 5 1
71 OVIYA 5 F 4 12.6 4700 P56L40E4 normal normal positive 1 0
72 MOHAMED 2 M 4,5,6,1 12.6 11200 P54L44E2 normal elevated positive 4 0
73 RAJASEKAR 5 M 4,8 13.6 5600 P54L42E4 elevated elevated positive 1 1
74 VASANTH 4 M 4,8 11.4 6700 P54L44E2 elevated normal negative 5 1
75 JANARTH 2 M 4,8 11.6 7800 P60L40 normal normal negative 1 0
76 BAVANI 10 F 3,4,7 9.8 10700 P58L38E2 normal elevated negative 1 0
77 NETHRA 4 F 4,6 10.8 8700 P56L44E2 elevated normal negative 1 1
78 UYUGENDRAN 10 M 3,4 9.9 6700 P56L40E4 normal normal negative 1 0
79 SRIKANTH 7 M 1,4 12.5 5800 P58L38E4 elevated normal positive 5 0
80 CHANDRA 5 F 1,4 11.4 4500 P60L38E2 normal elevated positive 1 1
81 MEHER 4 M 4,6 13.3 6700 P66L34 elevated normal positive 1 1
82 LEKHA 5 F 1,4,6 11.4 4100 P74L26 normal normal negative 1 0
83 MANOJ 7 M 3,4 13.4 5800 P68L30E2 normal elevated positive 1 0
84 JAYA 9 F 1,3,4 12.5 4500 P38L60E2 elevated elevated positive 1 0
85 SATHYA 5 F 4 13.4 6800 P54L42E4 elevated normal negative 5 1
86 PRAKASH 5 M 4 12.4 5400 P54L46 normal normal positive 1 0
87 CHANDRAN 6 M 4 12.7 5690 P60L40 normal normal negative 5 0
88 ALAGU 5 F 4 11.4 6400 P74L26 normal normal negative 1 0
89 ISAI 5 F 1,4,5,6 12.7 12300 P68L32 normal normal positive 4 0
90 MALARVIZHI 3 F 4,5,6,8,1 12.8 11000 P64L32E4 elevated elevated positive 4 1
91 SUNDARI 5 F 4,6,8 11.9 9800 P62L38 elevated normal negative 3 1
92 MAGESH 4 M 4 12.5 6300 P54L44E2 elevated normal negative 1 1
93 SETHU 8 F 4 13.1 4700 P74L26 normal normal negative 1 0
94 JACOB 3 M 4,6,5,8 11.3 11300 P58L40E2 normal normal positive 1 0
95 GIRI 5 M 4,5,6 12.5 12700 P56L40E4 elevated normal negative 3 1
96 ANISH 3 M 4 12 6400 P54L44E2 normal normal negative 1 0

KEY TO  MASTER CHART
PRESENTING COMPLAINTS:
Fever ( 1)
Rhinorrhoea ( 2)
Cough (3)
Breathlessness (4)
Poor feeding ( 5 )
Aspiration (6)
Ear discharge (7)
Excessive sleepiness (8)
Congenital heart disease( 9)
CHEST X RAY :
Bilateral Hyperinflation (1)
Atelectasis (2)
Increased bronchovascular markings(3)
Consolidation (4)
Normal (5)
PRECIPITATING FACTORS;
No factors (0)
Upper respiratory tract infection (1)
Chocolate (2)
Chilled food(3)
Fruit / nuts (4)
PARENTAL SMOKING:
Yes (1)
No (0)
FAMILY HISTORY OF ATOPY :
Yes (1)
No (0)
OCCURANCE OF WHEEZE:
Yes (1)
No (0)
